Cargando…

Gender disparities in multiple myeloma publications

Gender disparities exist in academia and are disproportionately affecting females. We conducted a cross‐sectional study to analyze gender disparities in multiple myeloma (MM) publications. A total of 679 publications with 8898 authorships were analyzed. The mean number of authors for females vs. mal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dweik, Aala, Dweik, Hadeel, Mian, Hira, Mohan, Meera, Schinke, Carolina, Al Hadidi, Samer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Short Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422002/ https://www.ncbi.nlm.nih.gov/pubmed/36051049 http://dx.doi.org/10.1002/jha2.470

Ejemplares similares

Variability of definition of high‐risk multiple myeloma across phase III clinical trials
por: Abu Za'nouneh, Faris Jamal, et al.
Publicado: (2023)

Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma
por: Alqazaqi, Raghad, et al.
Publicado: (2022)

Follow up duration of phase III Multiple Myeloma Clinical Trials: A systematic review
por: Ali, Mohammad O., et al.
Publicado: (2023)

Health Disparities Experienced by Hispanic Americans with Multiple Myeloma: A Systematic Review
por: Anampa-Guzmán, Andrea, et al.
Publicado: (2022)

Racial Differences in Spinal Cord Compression Related Hospitalizations in Patients with Multiple Myeloma
por: Al Hadidi, Samer, et al.
Publicado: (2023)

Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture
por: Al Hadidi, Samer, et al.
Publicado: (2017)

The Role of Monoclonal Antibodies in the Era of Bi-Specifics Antibodies and CAR T Cell Therapy in Multiple Myeloma
por: Mohan, Meera, et al.
Publicado: (2021)

Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis
por: Mazahreh, Farah, et al.
Publicado: (2023)

Ethnic Disparities in AL Amyloidosis Outcomes Among Hospitalized Patients in the United States
por: Al Hadidi, Samer, et al.
Publicado: (2022)

Depressive Symptoms and Complications Early after Acute Myocardial Infarction: Gender Differences
por: AbuRuz, Mohannad Eid, et al.
Publicado: (2018)

Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies
por: Fatoki, Raleigh Ayoolu, et al.
Publicado: (2022)

Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article
por: Hussain, Munawwar, et al.
Publicado: (2023)

Gender and early-career faculty disparities in hematology and oncology board review lecture series
por: Syaj, Sebawe, et al.
Publicado: (2022)

Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives
por: Shrivastava, Trilok, et al.
Publicado: (2023)

Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
por: Larsen, Kristin, et al.
Publicado: (2022)

Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
por: Schinke, Carolina, et al.
Publicado: (2022)

An Important Association With Lower Gastrointestinal Bleed: A Case of Heyde Syndrome
por: Dweik, Anass, et al.
Publicado: (2022)

Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant
por: Thalambedu, Nishanth, et al.
Publicado: (2023)

The Immune Microenvironment in Multiple Myeloma Progression at a Single-cell Level
por: Schinke, Carolina, et al.
Publicado: (2023)

A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time
por: Al-Awwal, Nasruddeen, et al.
Publicado: (2022)

Is aggressive treatment of smoldering myeloma the path to curing myeloma?
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023)

Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor–T Cell Therapy for Hematological Malignant Neoplasms
por: Al Hadidi, Samer, et al.
Publicado: (2022)

Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant
por: Thalambedu, Nishanth, et al.
Publicado: (2022)

A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy
por: Kleman, Ariel, et al.
Publicado: (2023)

Editorial: The role of the bone marrow microenvironment in multiple myeloma evolution and therapy
por: Schinke, Carolina, et al.
Publicado: (2023)

A gene signature can predict risk of MGUS progressing to multiple myeloma
por: Sun, Fumou, et al.
Publicado: (2023)

Gender Disparities in Cardiology-Related COVID-19 Publications
por: Vasti, Elena C., et al.
Publicado: (2021)

Racial Disparities in Plasma Cell Leukemia Outcomes Among Hospitalized Patients in the United States
por: Wu, Cindy, et al.
Publicado: (2023)

Gender Disparities in Academic Pain Medicine: A Retrospective, Cross-Sectional Bibliometric Analysis
por: Patel, Janki, et al.
Publicado: (2022)

Effects of Dual Peroxisome Proliferator-Activated Receptors α and γ Activation in Two Rat Models of Neuropathic Pain
por: Alsalem, Mohammad, et al.
Publicado: (2019)

MRD negativity: considerations for older adults with multiple myeloma
por: Mian, Hira, et al.
Publicado: (2023)

P-160: Disparities in multiple myeloma between hispanics and non-hispanics – real world outcomes
por: Shaikh, Hira, et al.
Publicado: (2022)

Disentangling age, gender, and racial/ethnic disparities in multiple myeloma burden: a modeling study
por: Huber, John H., et al.
Publicado: (2023)

Dissecting racial disparities in multiple myeloma
por: Marinac, Catherine R., et al.
Publicado: (2020)

Gender Disparities and Outcomes Of Acute Coronary Syndromes In Brazil
por: Lorenzo, Andrea De
Publicado: (2018)

Depressive symptoms, perceived control and quality of life among patients undergoing coronary artery bypass graft: a prospective cohort study
por: AbuRuz, Mohannad Eid, et al.
Publicado: (2022)

Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
por: Yarlagadda, Lakshmi, et al.
Publicado: (2021)

Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2022)

Use of daratumumab in high risk multiple myeloma: A meta‐analysis
por: Premkumar, Vikram, et al.
Publicado: (2020)

Update on the optimal use of bortezomib in the treatment of multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pvh0efupqarb5jhmcd46lqbgcd